Powerful pill can reveal what's going on in your gut — thanks to miniature sensors
Time to swallow your feelings.
It's no secret that gut health is being treated like the ultimate biohack these days, as ongoing research shows your digestive system impacts your skin, immune system, energy levels and even your mood.
Studies have even found links between the gut and Parkinson's, colon cancer and other conditions, with doctors routinely recommending people get more fiber in their diets.
Researchers at Caltech have developed a capsule that can measure your gut health.
T Mdlungu/peopleimages.com – stock.adobe.com
So it might be no surprise that the geniuses over at Caltech have invented a tiny pill called PillTrek that's lined with electrochemical sensors that measure pH, temperature, metabolites, ions — even serotonin and dopamine — right in your gut.
The pill is itty-bitty — measuring 7 millimeters in diameter and 25 millimeters in length — but it packs a powerful punch.
'We designed this pill to be a very versatile platform,' Wei Gao, a professor of medical engineering at Caltech and a Heritage Medical Research Institute Investigator, said in a press release.
'From an electrochemical-sensing point of view, it is very powerful. It has the ability to measure metabolites, ions, hormones such as serotonin and dopamine, possibly even proteins as well. And all within the gut, which is a complex environment.'
The PillTrek smart capsule measures just 7 millimeters in diameter and 25 millimeters in length.
Jihong Min and Wei Gao
Current gut tests rely on messy stool samples or pricey, invasive biopsies — and offer only snapshot insights.
Conversely, this smart capsule offers a window into a future where assessing your gut health — which is also a marker of overall health and a good way of detecting diseases early — can be relatively easy.
'Ingestible capsules have significant potential in diagnosis, monitoring and management of chronic conditions, but previous devices were very limited in terms of their sensing capabilities, lifetime, and size,' said Azita Emami, who is working with Gao to make the pill even smaller and more energy-efficient.
'This work is an important translational step toward devices that can provide meaningful medical information for patients and physicians.'
Researchers outlined the pill in a paper published in the journal Nature.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
an hour ago
- Boston Globe
Sage Therapeutics cuts more than 330 jobs after announcing its $795 million acquisition
Sage and Supernus could not immediately be reached for comment. With its planned purchase of Sage, Supernus will have access to Zurzuvae, the only postpartum depression drug approved by the Food and Drug Administration. 'This acquisition represents a major step in bolstering our future growth,' Supernus CEO Jack Khattar said in a statement. Advertisement The deal is expected to close in the third quarter of this year. The last few years have been rocky for Sage, which was founded in 2010 to research treatments for brain diseases and went public in 2014. The FDA failed to approve Zurzuvae to treat the more common major depressive disorder in 2023. Sage codeveloped the drug with Biogen, another Cambridge biotech. In August 2023, Sage Sage rejected a $469 million acquisition offer from Biogen in January, stating the offer undervalued the company. Advertisement Supernus, which has existed in different iterations for three decades, specializes in diseases of the central nervous system. The company has several commercial products for the treatment of Parkinson's disease, attention deficit/hyperactivity disorder, epilepsy and migraines. Marin Wolf can be reached at
Los Angeles Times
2 hours ago
- Los Angeles Times
Why Cycle Syncing on the Pill Supports Long-Term Wellness
In a wellness world pivoting from hacks to habits, cycle syncing has evolved beyond fertility tracking. It's now a core strategy in longevity, hormone balance, and performance optimization. But the latest twist? It's gaining traction with women on hormonal birth control, who technically don't have a cycle to sync with. That hasn't stopped experts and wellness influencers from promoting the benefits of mimicking monthly rhythms. With rising interest in burnout recovery, metabolic flexibility, and mood regulation, syncing food, fitness, and recovery to a simulated cycle isn't just feasible; it might be necessary. Dr. Jolene Brighten, hormone specialist and author of Beyond the Pill, breaks it down: 'Hormonal birth control suppresses ovulation and shuts down communication between the brain and ovaries, so your natural hormone fluctuations are flatlined.' Still, the gut, brain, metabolism, and immune systems (where hormones do their work) don't shut down. These systems crave structure. They respond to rhythm. And that's where simulated syncing comes in. Even without estrogen and progesterone fluctuations, the body still operates on circadian and ultradian rhythms. These cycles impact: By dividing the month into structured phases (energize/build vs. recover/regulate), you're providing your biology with a rhythm it can rely on. Goal: Energize mitochondria, build lean tissue, support detox Red light therapy boosts mitochondrial function and energy. A 2024 Nature review confirmed it improves ATP production through cytochrome c oxidase activation. Another clinical study showed a 27.7% drop in post-meal glucose spikes after red light exposure, improving metabolic flexibility, ideal for this simulated high-energy window. To support hormonal detox, focus on cruciferous vegetables like broccoli and kale, which aid estrogen metabolism. For deeper gut support, incorporate fermented foods like kimchi and kefir, which can offset inflammation and nutrient malabsorption common on the pill. Goal: Lower inflammation, balance insulin, support mood This phase mimics the wind-down of a natural cycle. You're not hormonally shifting, but syncing behavior to a slower rhythm supports mood and insulin sensitivity. Studies have found that an infrared sauna plus massage increases lymph flow and can reduce cortisol, which is ideal for supporting recovery from workouts or synthetic hormone buildup. Layer in functional fats and gut-rebuilding prebiotics to reset microbiome integrity after months (or years) on synthetic hormones. Hormonal birth control has been linked to the depletion of several key nutrients (including magnesium, zinc, folate, vitamins B6 and B12, and selenium), all essential for neurotransmitter synthesis, metabolic detoxification, and hormonal resilience. Hormonal contraceptives can impact mood, digestion, and skin through nutrient depletion. Adopting a hormone-balancing diet (rich in B vitamins, magnesium, and fermented foods) has been shown to reduce common side effects of birth control, including fatigue, brain fog, and breakouts. To support recovery and rebalance the system, Dr. Jolene Brighten recommends: For more rapid repletion, especially during post-pill transition, IV nutrient therapy can deliver key vitamins and minerals directly into circulation, supporting cellular energy and faster recovery. Cycle syncing isn't just about hormones; it's about rhythm. And rhythm, according to brain experts, is medicine. 'Neuroplasticity offers a way for maintaining or even improving cognitive health during perimenopause and menopause and beyond,' says Dr. Sarah de la Torre, clinical lead at Respin Health. Simulated syncing restores structure, sleep quality, and cognitive rhythm, all of which support memory, focus, and mental agility. It's biohacking for the brain. These example routines show how to align daily habits with the simulated follicular and luteal phases. They're obviously not prescriptions, but adaptable frameworks designed to help structure your energy, recovery, and nutrition rhythms throughout the month. Even your skincare can sync: Mūhza's cycle-specific skin protocol uses hormone-informed ingredients to soothe or activate the skin depending on your simulated cycle phase. The gut-skin-hormone axis is foundational to modern syncing. A report on hormone-reset diets emphasized microbiome health as a first step to restoring estrogen balance and reducing inflammation. Pill-induced dysbiosis can linger for months. Supporting your gut with fermented foods, seasonal diversity, and polyphenol-rich plants helps regulate blood sugar, improve skin, and reduce mood instability, especially in later cycle phases. Whether you're bleeding or not, your body craves rhythm. In an era of nonstop cortisol, poor sleep, and mood volatility, cycle syncing can offer a simple, science-backed way to ground your biology. Click here to learn more about Dr. Brighten
Yahoo
4 hours ago
- Yahoo
Why a database of bug genes could be one of Trump's most devastating cuts at Harvard
For decades, scientists have gleaned information from the antennae, brains and even ovaries of millimeter-sized fruit flies for medical research as varied as Alzheimer's, Parkinson's, addiction, traumatic brain injuries, birth defects and nerve regeneration. But President Donald Trump's sweeping biomedical research cuts at Harvard University threaten the world's only repository of that data. The free website FlyBase, considered the 'Wikipedia of fruit fly research' among scientists worldwide, is a project under Harvard's stewardship. It recently saw its funding terminated by the National Institutes of Health. 'There really isn't a second version of what we do,' said Victoria Jenkins, a genome database coordinator at Harvard's Department of Molecular and Cellular Biology. 'We are the one resource for this information.' Read more: 'Devastating': 10 Harvard researchers detail 'essential' work set to be cut by Trump The reason why a database containing information about every fruit fly (or Drosophila) gene and genome is so important? The bug typically associated with rotting fruits and vegetables happens to share nearly 70% of its DNA structure with humans, making them ideal test subjects in many cases, researchers say. Discoveries fueled by fruit fly research have been honored by the Nobel Prize six times, dating back to 1933. The May termination of FlyBase's NIH grant puts at risk the future of the project, containing 32 years worth of data. 'There are a lot of unexpected places that very common, big discoveries come from,' fruit flies included, Jenkins said. Jenkins is one of the people who keeps FlyBase, a partnership between four universities, running. She extracts, interprets and archives data to make it accessible to the public and other researchers. Before working with FlyBase, Jenkins did hands-on research with fruit flies, looking at their genes involved in stem cell regulation. Using carbon dioxide, she would anesthetize them on a plate in order to physically handle them. Read more: Harvard researcher's work gives 'hope' for Parkinson's. But the feds cut his funding Susan Russo, the program director of FlyBase who is based at Harvard, said bone morphogenetic proteins — which help form bone and cartilage — were understood using fruit flies, 'and flies don't even have bones.' 'People say, why a fruit fly? It's a model organism that's used before clinical trials for human diseases,' Russo said. 'It's basic science and translational investigations — ultimately things that go to clinical trials. It's been critical for human disease.' FlyBase is a multi-university partnership between Harvard, Indiana University Bloomington, University of New Mexico and University of Cambridge in the United Kingdom. Because Harvard was the NIH grant awardee, the termination ceased funding for all of the involved entities. Now, researchers are seeking financial support elsewhere to preserve the website as is — at the very least. The European researchers are fundraising across the pond, while the U.S.-based operations work on their own mechanisms to collect emergency dollars. Read more: Trump cuts threaten 'irreplaceable' Harvard stockpile of human feces, urine Both Jenkins and Russo claimed FlyBase's association with Harvard was the central reason why it's funding was cut. Pressuring the elite university to change its policies and surrender sensitive data in the name of antisemitism, the Trump administration has inundated Harvard with a barrage of funding and grant revocations, as well as actions trying to stop its ability to enroll international students. Last week, Trump said his administration could be nearing a deal with Harvard, but few details are currently known. Harvard is also actively suing the administration in two separate federal court lawsuits. In a statement, NIH told MassLive that all federal funds to Harvard currently remain paused as part of the administration's multi-agency Task Force to Combat Anti-Semitism. The agency cited Trump's executive order on 'Additional Measures to Combat Anti-Semitism,' related to rooting out antisemitism on college campuses. 'NIH remains committed to supporting high-quality, taxpayer-funded science — free from ideological agendas and political bias,' the agency said. 'If Harvard meets the standards set by the Administration, FlyBase investigators will regain access to funding and will be able to continue their important work in advancing biomedical research.' Jenkins, whose entire salary is funded by the federal government, called fruit fly research 'incredibly cost-effective,' making the grant revocation all the more frustrating. 'Flies are inexpensive,' she said. 'They're easy to work with, easy to get started, and they don't have a lot of the ethical concerns associated with other animals. The amount of work you can do is so much easier.' A Nobel Prize in Physiology or Medicine was awarded to fruit fly research as recently as 2017 for 'the discovery of molecular mechanisms controlling the circadian rhythm.' Using fruit flies as models, the researchers were able to isolate a gene that controls the normal daily biological rhythm. Liqun Luo, a professor of biology at Stanford University, recently told The Transmitter, a neuroscience online publication, 'it would be a disaster' if FlyBase 'goes dark.' According to its NIH grant description, FlyBase enables more than 4,000 research laboratories to further their work. While Harvard announced in May it would dole out $250 million as a stopgap for its researchers facing funding cuts, its FlyBase employees don't know yet if they'll be eligible. The immediate goal, Jenkins and Russo said, is to capture the database as is so they can ultimately migrate it over to a larger website initiative funded by the National Human Genome Research Institute. When complete, that website will consolidate genetic model organism data — including worms, zebrafish, rats and fruit flies — in one place. Harvard Kennedy's backup plan for foreign students: Study online, or in Canada Judge rules Trump can't invoke national security powers to ban foreign Harvard students Harvard's Jewish faculty have their own wish list for a deal with Trump These 16 states are supporting the Trump admin in lawsuit with Harvard Read the original article on MassLive.
